We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Clean bill

22 June 2015 By Robert Cyran

The $54 bln bid puts an extra $12 bln onto the value of its rival’s equity. Cigna is playing hard to get for good reason, though. The possibility of other suitors gives its defense validity. Cost savings and the implied return on investment also suggest Anthem has wiggle room.

This content is for Subscribers only

To access full Breakingviews.com content you must be a subscriber. Please use the following link to request a trial.

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)